Is migraine a neuropathic pain syndrome?

被引:51
作者
Biondi D.M. [1 ]
机构
[1] Headache Management Program, Spaulding Rehabilitation Hospital, Boston, MA 02114
关键词
Migraine; Neuropathic Pain; Migraine Attack; Chronic Migraine; Migraine With Aura;
D O I
10.1007/s11916-006-0042-y
中图分类号
学科分类号
摘要
The understanding of migraine pathophysiology has evolved from the belief that migraine is a vascular disorder, to evidence that better defines migraine as a neurogenic disorder associated with secondary changes in brain perfusion. There is evidence to suggest that the early phase of migraine pain results from neurogenic inflammation affecting cranial blood vessels and dura. Allodynia, hyperalgesia, and expansion of nociceptive fields occur during most well-established migraine attacks. These clinical features of migraine are evocative of those traditionally associated with neuropathic pain. A hypothesis that defines migraine pain as a unique neuropathic pain disorder can imply the potential for neural plasticity and may provide insight into the mechanisms that underlie the transformation of episodic to chronic forms of migraine. The neuropathic pain model of migraine pathophysiology not only paves the way for mechanism-based treatment strategies that can improve the acute and preventive management of migraine attacks, but also opens the door for the discovery of novel therapeutic targets. It also lends momentum to an understanding of clinically intriguing topics such as opiate-induced hyperalgesia and medication-overuse headache (rebound headache), opioid resistance in the treatment of chronic headache, and disease modification in defending against the potential for migraine transformation. Copyright © 2006 by Current Science Inc.
引用
收藏
页码:167 / 178
页数:11
相关论文
共 96 条
  • [21] Rapoport A.M., Stang P., Gutterman D.L., Et al., Analgesic rebound headache in clinical practice: Data from a physician survey, Headache, 36, pp. 14-19, (1996)
  • [22] Vingen J.V., Sand T., Stover L.J., Sensitivity to various stimuli in primary headaches: A questionnaire study, Headache, 39, pp. 552-558, (1999)
  • [23] Mathew N.T., Stubits E., Nigam M., Transformation of migraine into daily headache: Analysis of factors, Headache, 22, pp. 66-68, (1982)
  • [24] Lipton-Dahlof P., Linde M., Dahlof C., Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: A retrospective study, Cephalalgia, 20, pp. 658-662, (2000)
  • [25] Fritsche G., Eberl A., Katsarava Z., Et al., Drug-induced headache: Long-term follow-up of withdrawal therapy and persistence of drug misuse, Eur Neurol, 45, pp. 229-235, (2001)
  • [26] Katsarava Z., Fritsche G., Muessig M., Et al., Clinical features of withdrawal headache following overuse of triptans and other headache drugs, Neurology, 57, pp. 1694-1698, (2001)
  • [27] Silberstein S.D., Silberstein J.R., Chronic daily headache: Prognosis following inpatient treatment with repetitive IV DHE, Headache, 32, pp. 439-445, (1992)
  • [28] Diener H.C., Dahlof C.G., Headache associated with chronic use of substances, The Headaches, pp. 871-878, (2000)
  • [29] Scher A.I., Lipton R.B., Stewart W.F., Natural history and prognostic factors for chronic daily headache: Results from the Frequent Headache Epidemiology Study, Neurology, 58, SUPPL. 3, (2002)
  • [30] Lu S.R., Fuh J.L., Chen W.T., Et al., Chronic daily headache in Taipei, Taiwan: Prevalence, follow-up, and outcome predictors, Cephalalgia, 20, pp. 900-906, (2001)